Group Completes First Dose of Stem Cells for Bradykinesia
News
IMAC Holdings has completed dosing the first group of participants in a Phase 1 clinical trial evaluating its investigational umbilical cord-derived mesenchymal stem cells (MSCs) as a potential treatment for ... Read more